697-698
Original
Prevalence and evolution of newly diagnosed autoimmune gastritis in a large Spanish retrospective cohort
DOI: 10.17235/reed.2025.11101/2025
Genetic map of Wilson disease in Spain - A great tool to improve diagnosis and screening
DOI: 10.17235/reed.2025.11005/2024
Letter
Acute pancreatitis as the initial manifestation of an ampullary neuroendocrine tumor
DOI: 10.17235/reed.2024.10567/2024
Abernethy syndrome as a cause of liver transplantation
DOI: 10.17235/reed.2024.10561/2024
Lymphoepithelioma-like carcinoma: a rare case of rectal cancer
DOI: 10.17235/reed.2024.10540/2024
Impact of ustekinumab exposure on clinical outcomes during induction in inflammatory bowel disease
DOI: 10.17235/reed.2024.10521/2024
Small bowel obstruction — A rare complication after endoscopic transcecal appendectomy
DOI: 10.17235/reed.2024.10474/2024
Gastric neuroendocrine tumor presenting with carcinoid syndrome
DOI: 10.17235/reed.2024.10364/2024
Are intracystic chromogranin A and neuron-specific enolase useful in the diagnosis of cystic pancreatic neuroendocrine tumors?
DOI: 10.17235/reed.2024.10145/2023
An early-stage primary signet ring cell carcinoma of the colon
DOI: 10.17235/reed.2023.10016/2023
Ligation-assisted endoscopic mucosal resection for a duodenal neuroendocrine tumor
DOI: 10.17235/reed.2023.9985/2023
Digestive Diseases Image
Endoscopic submucosal dissection coupled with “modified clip coupled with elastic ring” traction removing rectal neuroendocrine tumor
DOI: 10.17235/reed.2023.9952/2023
An uncommon cause of intestinal obstruction: Vanek’s tumor
DOI: 10.17235/reed.2023.9914/2023
An unusual cause of abdominal pain in an older female
DOI: 10.17235/reed.2023.9898/2023
“Grey areas” in large rectal neuroendocrine tumors: when endoscopic ultrasound becomes the silver lining
DOI: 10.17235/reed.2023.9893/2023
Sustained silence of a small signet ring cell carcinoma
DOI: 10.17235/reed.2023.9891/2023
Pancreatic schwannomaPancreatic schwannoma: a rare tumor of the pancreasa rare tumor of the pancreas
DOI: 10.17235/reed.2023.9840/2023
Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome
DOI: 10.17235/reed.2023.9815/2023
Editorial
Diagnosis and management of Abernethy syndrome
DOI: 10.17235/reed.2023.9781/2023
Gastric variceal bleeding as a form of presentation of a pancreatic neuroendocrine tumor
DOI: 10.17235/reed.2023.9757/2023
Multiple neuroendocrine tumors in the stomach, duodenum and pancreas of a MEN1 patient
DOI: 10.17235/reed.2023.9756/2023
Colocolic intussusception by lipoma in the transverse colon. A cause of intestinal obstruction
DOI: 10.17235/reed.2023.9690/2023
Unexpected cause of chronic recurrent abdominal pain: mesenteric arteriovenous dysplasia/vasculopathy
DOI: 10.17235/reed.2023.9689/2023
Surgical indication of type I gastric neuroendocrine tumors
DOI: 10.17235/reed.2023.9681/2023
Unusual presentation of jejunal adenocarcinoma and ovarian metastasis
DOI: 10.17235/reed.2023.9658/2023
Management and endoscopic treatment of rectal neuroendocrine tumors
DOI: 10.17235/reed.2023.9656/2023
“Clip coupled with an elastic ring” internal traction for endoscopic submucosal dissection of a rectal neuroendocrine tumor: a junior endoscopist experience
DOI: 10.17235/reed.2023.9617/2023
Intestinal obstruction due to pneumatosis intestinalis
DOI: 10.17235/reed.2023.9608/2023
Icteric syndrome secondary to polycystic liver disease
DOI: 10.17235/reed.2023.9590/2023
Lower gastrointestinal bleeding as an uncommon form of presentation in a small intestine neuroendocrine tumor
DOI: 10.17235/reed.2023.9583/2023
Submucosal infiltrate of Anisakis larvae. A rare cause of intestinal obstruction
DOI: 10.17235/reed.2023.9582/2023
Endoscopic management of gastric neuroendocrine tumors: an analysis of 50 cases
DOI: 10.17235/reed.2023.9570/2023
Intestinal obstruction secondary to Brunner’s glands hyperplasia
DOI: 10.17235/reed.2023.9538/2023
Carcinoid syndrome and somatostatin analogues
DOI: 10.17235/reed.2023.9525/2023
A rare case of an esophageal neuroendocrine carcinoma arising on an endoscopic resection scar
DOI: 10.17235/reed.2023.9523/2023
Transmural or mucosal healing in Crohn´s disease. Which is the goal to be pursued?
DOI: 10.17235/reed.2023.9492/2023
Diffuse gastric adenocarcinoma during pregnancy and genetic counseling
DOI: 10.17235/reed.2022.9412/2022
Duodenal neuroendocrine tumors: analysis of 20 cases and endoscopic treatment
DOI: 10.17235/reed.2023.9401/2022
Duodenal diastatic perforation due to double gastric and jejunal trichobezoar in a patient with Rapunzel syndrome
DOI: 10.17235/reed.2023.9394/2022
Diagnosis of a cystic pancreatic neuroendocrine tumor: is cystic fluid chromogranin A useful?
DOI: 10.17235/reed.2022.9366/2022
Iatrogenic Small Intestinal Obstruction
DOI: 10.17235/reed.2022.9225/2022
A “push-and-pull” trick for endoscopic removal of buckyballs impacted in the esophagus and gastric fundus
DOI: 10.17235/reed.2022.9222/2022
Intrahepatic sarcomatoid cholangiocarcinoma: a rare cholangiocarcinoma subtype
DOI: 10.17235/reed.2022.9130/2022
A gastric neuroendocrine tumor after prolonged use of proton pump inhibitors
DOI: 10.17235/reed.2022.9126/2022
Is long-term follow-up solely by imaging tests safe in non-operated pancreatic neuroendocrine tumors?
DOI: 10.17235/reed.2023.9293/2022
Neuroendocrine tumor of the ampulla of Vater. Review of the literature
DOI: 10.17235/reed.2022.8981/2022
Endoscopic resolution of intestinal obstruction secondary to colonic gallstone ileus and radicular stenosis of the sigma
DOI: 10.17235/reed.2022.8905/2022
Predictive value of patency capsule and magnetic resonance enterography for capsule endoscopy retention in patients with established Crohn’s disease
DOI: 10.17235/reed.2022.8848/2022
Ectopic ACTH syndrome in a patient with Crohn’s disease
DOI: 10.17235/reed.2022.8825/2022
GIST. Duodenopancreatectomía. Tumor neuroendocrino no funcionante.
DOI: 10.17235/reed.2022.8753/2022
Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort
DOI: 10.17235/reed.2022.8777/2022
Efficacies of prokinetics and rifaximin on the positivity of a glucose breath test in patients with functional dyspepsia: a randomized trial
DOI: 10.17235/reed.2022.8735/2022
Primary adenocarcinoma of the fourth portion of the duodenum, an unsuspected diagnosis
DOI: 10.17235/reed.2022.8732/2022
Endoscopic and ultrasound image of an ileocolic intussusception. An unusual finding in adult patients
DOI: 10.17235/reed.2022.8729/2022
Pharmacokinetic and clinical monitoring through posologic changes in adalimumab intensification regimen from 40 mg every week to 80 mg every other week
DOI: 10.17235/reed.2022.8560/2021
Gastric ulcer with liver penetration
DOI: 10.17235/reed.2022.8528/2021
Small pancreatic neuroendocrine tumors: observing and monitoring or prompt surgical resection
DOI: 10.17235/reed.2021.8419/2021
Evaluation of online content of proctological disorders in the Portuguese language
DOI: 10.17235/reed.2021.8333/2021
An incidental hepatic epithelioid hemangioendothelioma in a patient with chronic hepatitis: lost in the maze
DOI: 10.17235/reed.2021.8322/2021
Off-label use of 0.4 % sodium hyaluronate teardrops for endoscopic resection of a rectal carcinoid
DOI: 10.17235/reed.2021.8318/2021
Endoscopic resection of a duodenal neuroendocrine tumor
DOI: 10.17235/reed.2021.8232/2021
Comparison of phenotypes and outcomes following resection of incidental versus symptomatic pancreatic neuroendocrine tumors
DOI: 10.17235/reed.2021.8096/2021
Appendiceal goblet-cell adenocarcinoma: a rare cause of acute appendicitis
DOI: 10.17235/reed.2021.8056/2021
Abdominal cocoon sign: an unusual cause of intestinal obstruction
DOI: 10.17235/reed.2021.8057/2021
Adenocarcinoma of the small intestine in Crohn's disease
DOI: 10.17235/reed.2021.8050/2021
Review
Current clinical and research fluid biomarkers to aid risk stratification of pancreatic cystic lesions
DOI: 10.17235/reed.2021.7948/2021
Endoscopic forceps removal for complicated magnetic beads impaction
DOI: 10.17235/reed.2021.7731/2020
Double strangeness: a young male with intestinal obstruction secondary to gastrointestinal follicular lymphoma
DOI: 10.17235/reed.2020.7656/2020
Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival
DOI: 10.17235/reed.2021.7638/2020
Intestinal obstruction caused by Anisakis
DOI: 10.17235/reed.2020.7409/2020
Diagnostic yield of the capsule endoscopy and enteroscopy combination for early small bowel carcinoid tumors
DOI: 10.17235/reed.2020.7262/2020
Genetic alterations in colorectal cancer: implications for the prognosis and treatment of the disease
DOI: 10.17235/reed.2020.7209/2020
Radioguided detection of a non-palpable occult lesion (ROLL) in a case of abdominal metastasis of a neuroendocrine tumor
DOI: 10.17235/reed.2020.6926/2020
Management of distal intestinal obstruction syndrome by enteroscopy in a post-lung transplant patient
DOI: 10.17235/reed.2020.6908/2020
An esophageal neuroendocrine tumor in a Barrett’s esophagus successfully treated with endoscopic resection
DOI: 10.17235/reed.2020.6907/2020
Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients
DOI: 10.17235/reed.2020.6857/2020
Random biopsies in patients harboring a CDH1 mutation: time to change the approach?
DOI: 10.17235/reed.2020.6720/2019
A rare cause of extrahepatic biliary tract stricture: a neuroendocrine carcinoma
DOI: 10.17235/reed.2020.6491/2019
Klatskin-mimicking neuroendocrine tumor
DOI: 10.17235/reed.2019.6382/2019
Signet ring cell carcinoma in a juvenile polyp
DOI: 10.17235/reed.2019.6299/2019
Barrett’s esophagus: “All diseases are divine and all are human”
DOI: 10.17235/reed.2019.6261/2019
Case Report
Life-threating diarrhea and acute renal failure secondary to pancreatic VIPoma treated by surgery
DOI: 10.17235/reed.2019.6244/2019
Laparoscopic management of a small bowel obstruction caused by an endometriotic focus
DOI: 10.17235/reed.2019.6220/2019
Appreciation of the treatment in adult patients with congenital portosystemic connections in relation with their symptoms
DOI: 10.17235/reed.2019.6210/2019
Clinical characteristics and genetic profiles of young and adult patients with cholestatic liver disease
DOI: 10.17235/reed.2019.6168/2019
Spontaneous splenoazygos shunt in a patient with portal hypertension: an exceedingly rare occurrence
DOI: 10.17235/reed.2019.6091/2018
Readmission rates after laparoscopic cholecystectomy: are they affected by ERCP prior to surgery?
DOI: 10.17235/reed.2019.6021/2018
Aganglionic megacolon in the adult. Urgent and surprising cause of intestinal occlusion
DOI: 10.17235/reed.2019.5922/2018
Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn’s disease
DOI: 10.17235/reed.2018.5691/2018
Lower gastrointestinal bleeding as a form of presentation in an adult case of Abernethy syndrome
DOI: 10.17235/reed.2018.5615/2018
Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease
DOI: 10.17235/reed.2019.5600/2018
Retroperitoneal schwannoma
DOI: 10.17235/reed.2018.5569/2018
Online social networks and inflammatory bowel disease
DOI: 10.17235/reed.2018.5496/2018
Letter to the Editor
Author´s reply: Cystic pancreatic neuroendocrine tumors. A diagnostic challenge
DOI: 10.17235/reed.2018.5415/2017
HLA-DQ distribution and risk assessment of celiac disease in a Spanish center
DOI: 10.17235/reed.2018.5399/2017
Cystic pancreatic neuroendocrine tumor. Pancreatic endocrine or neuroendocrine tumor. Endoscopic ultrasonography.
DOI: 10.17235/reed.2017.5390/2017
The morphological and functional diagnosis of a rare entity: lipomatous pseudohypertrophy of the pancreas
DOI: 10.17235/reed.2018.5367/2017
Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information
DOI: 10.17235/reed.2018.5331/2017
Hemorrhage and intestinal obstruction secondary to a Meckel’s diverticulum: a case report
DOI: 10.17235/reed.2017.5219/2017
The long-term recurrence rate and survival of obstructive left-sided colon cancer patients: a stent as a bridge to surgery
DOI: 10.17235/reed.2018.5077/2017
Cystic pancreatic neuroendocrine tumors (cPNETs): a systematic review and meta-analysis of case series
DOI: 10.17235/reed.2017.5044/2017
Right-colon mucinous adenocarcinoma mimicking a hydatid cyst
DOI: 10.17235/reed.2017.5041/2017
A case of a mixed adenoneuroendocrine tumor of the colon
DOI: 10.17235/reed.2017.5008/2017
Synchronous intraductal papillary mucinous neoplasm and a pancreatic neuroendocrine tumor: more than a coincidence?
DOI: 10.17235/reed.2017.5003/2017
Neuroendocrine tumors of the pancreas: keys issues in dealing with heterogeneity
DOI: 10.17235/reed.2017.4997/2017
Pancreatic neuroendocrine tumors. Prognostic factors
DOI: 10.17235/reed.2017.5109/2017
Chronic diarrhea, weight loss and heart failure. Features of the same disease?
DOI: 10.17235/reed.2017.4874/2017
A rectal neuroendocrine neoplasm
DOI: 10.17235/reed.2017.4836/2017
Artifacts of the common bile duct caused by duodenal metallic hemoclip on magnetic resonance cholangiopancreatography
Pancreatic neuroendocrine tumors
DOI: 10.17235/reed.2017.4725/2016
Pancreas neuroendocrine tumors - not so rare or benign
DOI: 10.17235/reed.2016.4672/2016
Genetics in idiopathic pancreatitis and acute recurrent pancreatitis
DOI: 10.17235/reed.2017.4632/2016
Leptomeningeal carcinomatosis in a young patient with obstructive colorectal signet- ring cell adenocarcinoma
DOI: 10.17235/reed.2017.4602/2016
An unusual enterolith ileus
Diagnosis and management of patients with an intermediate probability of choledocholithiasis
DOI: 10.17235/reed.2017.4549/2016
Unusual presentation of obstructive jaundice
DOI: 10.17235/reed.2017.4501/2016
Alopecia areata as a paraneoplastic syndrome of gastric cancer
DOI: 10.17235/reed.2016.4455/2016
Jejunal pseudodiverticulosis. Three cases report
DOI: 10.17235/reed.2017.4403/2016
Liver metastasis secondary to primary mesenteric carcinoid
Anisakiasis and intestinal endometriosis: under-recognized conditions in the differential diagnosis of acute abdomen
DOI: 10.17235/reed.2016.4393/2016
A single institution’s 21-year experience with surgically resected pancreatic neuroendocrine tumors: an analysis of survival and prognostic factors
DOI: 10.17235/reed.2016.4323/2016
Mixed adenoneuroendocrine carcinoma (MANEC) of the gastroesophageal junction: a case report and review of the literature
DOI: 10.17235/reed.2016.4315/2016
Intestinal endometriosis. Our experience
DOI: 10.17235/reed.2016.4292/2016
Gastric invagination in adults as a rare cause of constitutional syndrome
Mesenteric schwannoma: an unusual cause of abdominal mass
DOI: 10.17235/reed.2016.4202/2016
A recurrence of pancreatic non-functioning neuroendocrine tumor mimicking splenosis
Is there any relationship between drug addiction and the development of a signet ring cell carcinoma of the stomach?
DOI: 10.17235/reed.2016.4070/2015
Gastric neuroendocrine tumor presenting with gastrointestinal bleeding
DOI: 10.17235/reed.2015.3998/2015
Surgical management of appendiceal adenocarcinoid. Case report and literature review
DOI: 10.17235/reed.2016.4049/2015
Primary non-functioning neuroendocrine tumor of the extrahepatic bile duct
DOI: 10.17235/reed.2016.4071/2015
Contribution of infliximab population pharmacokinetic model for dose optimization in ulcerative colitis patients
DOI: 10.17235/reed.2015.3978/2015
Hirschsprung disease with debut in adult age as acute intestinal obstruction: case report
DOI: 10.17235/reed.2016.3841/2015
TIPS treatment in a patient with severe lower gastrointestinal bleeding with a misdiagnosis of cirrhotic portal hypertension
DOI: 10.17235/reed.2015.3794/2015
Pelvic inflammatory myofibroblastic tumor mimicking a rectal cancer
DOI: 10.17235/reed.2015.3777/2015
Download the citation for this article by clicking on one of the following citation managers:
Received: 24/11/2014
Accepted: 21/01/2015
Published: 30/10/2015
Article revision time: 55 days
Article editing time: 340 days
Submission and tracking
Access to the information published on the website (www.reed.es) of the Sociedad Española de Patología Digestiva (SEPD), Calle Sancho Dávila, 6, 28028 Madrid, CIF: G28486280, telephone: 914021353, e-mail: sepd@sepd.es, implies acceptance of the following conditions of use:
1. The SEPD published its website in order to make it easier for potential visitors to access information related to its services. The information displayed on this website is made available to users accessing the website, both privately and individually, at no additional cost. The commercialization of access rights is expressly prohibited.
2. It is expressly forbidden to copy or reproduce the information published by means of any electronic medium (web pages, databases, web pages or electronic publications) that allows the dissemination of any information published on this website to multiple users without the prior written consent of the SEPD.
3. Accuracy of information: The SEPD endeavors to display accurate and up-to-date information on its website. However, the SEPD is not responsible for the consequences of reading this information.
4. SEPD is not liable for any damages that the user may cause in connection with access to this website or the use of its contents.
5. Notice to users and/or patients: The information included in www.reed.es is for the exclusive use of healthcare professionals and this will be stated in the registration and access alert.
6. Funding: REED, the official scientific body of the EDPS, shares the same sources of funding as the EDPS, as laid down in Article 22, SECTION VII (ECONOMIC AND DOCUMENTARY SYSTEM) of the EDPS's Statutes.
The website http://www.reed.es may host advertising from third parties that may be considered of interest to the user and in no way a source of budgetary funding for the website. Wherever the word 'Advertising' is displayed, it will be highlighted.
However, advertising that infringes Law 29/2006 on guarantees and rational use of medicines and health products will not be accepted. Likewise, there will be no advertising of any kind in those areas of the website where there may be a conflict of interest.
Advertisers have no rights over their editorial content.
7. Access to restricted areas: In relation to access to restricted areas where the user voluntarily completes the registration form, the EDPS will assign the user a password which will be sent to the e-mail address provided by the user, who must make diligent use of the password and keep it secret. Consequently, the user accepts that he/she is responsible for the correct custody and confidentiality of the password/identifier provided by the EDPS. Furthermore, the user shall not provide access to third parties, either temporarily or permanently, or allow access to third parties.
Consequently, the user is solely responsible for all accesses, contents and actions he/she carries out in connection with his/her user ID and access code, with full indemnity for the EDPS.
On this basis, the user is responsible for immediately informing the EDPS of any factors that allow the misuse of the IDs and/or passwords, such as theft, loss or unauthorized access, in order to cancel them immediately. Until such incidents are reported, SEPD will not be liable for any liability that may arise from the misuse of identifiers or passwords by unauthorized third parties.
The user understands and accepts that he/she is accessing a website with content intended exclusively for medical staff and acknowledges that he/she is a healthcare professional.
Notes of interest to members and visitors to the EDPS website: The data and information contained in all content on these websites are only guidance documents for members and are therefore not legally binding.
8. License for public use of the website: is governed by Spanish law, regardless of the country in which the user accesses the website. Any controversy that may arise in the interpretation of these rules of access will be resolved before the Spanish Courts and Tribunals.
Copyright and Creative Commons POR NC ND: The total or partial reproduction of texts and graphics by any means is prohibited without the express written authorization of the EDPS. To insert these texts, images or news items in the publication or dissemination in any medium of any kind accessible to third parties, the express written consent of the EDPS must be obtained.
The private use of the texts, news and data published on this website is strictly for personal purposes.
The General Data Protection Regulation (Regulation (EU) 2016/679) harmonizes Data Protection legislation across the European Union, increasing the protection of individuals and giving them greater control over their personal data.
At the Spanish Society of Digestive Pathology (SEPD), we have always been concerned about the protection of personal data. We have therefore updated our Privacy Policy in order to bring it into line with the new regulations and to inform you of the changes that affect your rights:
Responsible for the processing of your personal data: SOCIEDAD ESPAÑOLA DE PATOLOGÍA DIGESTIVA (SEPD), CIF: G28486280 and registered office at Calle Sancho Dávila 6, 28028 Madrid.
The data collected by the Sociedad Española de Patología Digestiva (SEPD) are obtained in different ways (website, e-mail, electronic forms or on paper) through its activity as a business association and service provider; these data will become part of an information file for which it is responsible.
Purpose of data collection:
Legitimacy of the processing:
Recipients of the data.
Data subjects:
Everyone can know whether or not the EDPS processes their personal data. They have the right to:
SEPD will cease to process the data, except for legitimate reasons, or for the exercise or defense of possible claims.
Origin of the data: SEPD will obtain personal data directly from the data subject through the following communication channels:
Categories of data:
Sending of commercial communications: In accordance with the LSSI, Law 34/2002, and Law 29/2009, of 30 December, if you do not wish to receive any more commercial communications, please send an e-mail with the word BAJA (unsubscribe) to the following address: sepd@sepd.es.
Security measures: SEPD informs that it has adopted all necessary security measures to prevent theft, alteration or unauthorized access to data, taking into account the state of the art, the costs of implementation, the nature, scope, context and purpose of the processing, as well as the variable risks of probability and severity to the rights and freedoms of individuals, such as in cases of outsourced services, request and ensure that the controller implements appropriate technical and organizational measures to ensure an adequate level of security against existing threats, as stated in art. 32 of the Data Protection Regulation.
Exercise of rights:
Everyone has the right to know whether the EDPS processes his or her personal data. He or she also has the right to:
Access their personal data,
Request the rectification of inaccurate data.
Request deletion when, among other reasons, the data are no longer necessary for the purposes for which they were collected.
Object to the processing of your data, on grounds relating to your particular situation, by requesting that they not be processed by the EDPS.
In certain circumstances, request the restriction of the processing of your data, in which case they will only be kept for the exercise or defense of claims.
Withdraw, at any time, the consent given, without this affecting the lawfulness of the processing that we have carried out prior to such withdrawal.
The interested party may exercise their rights at the following address: Sociedad Española de Patología Digestiva (SEPD), c/ Calle Sancho Dávila, 6 28028 Madrid, or by email to the following address: sepd@sepd.es, any controversy that may arise in the interpretation of these access rules will be resolved before the Spanish Courts and Tribunals.
Remember that whenever you exercise any of the rights set out above, you must accompany your request with a copy of your ID card or equivalent document that allows us to verify your identity.
Likewise, if you are not satisfied with how we have dealt with your rights, you may file a complaint with the Spanish Data Protection Agency, through the website www.aepd.es.
The following table describes in detail the cookies present on the website
The user has also been informed of the cookies used by this website by means of the banner that appears on the home screen during the first browsing visit to this website, in which the user can configure them at their own discretion, requesting their consent and management.
A cookie is a small piece of information, usually a few kilobytes to several megabytes in size, which is stored on your terminal when you visit our website. The cookie is used to remember your preferences and other information about your browsing history of our website.
Cookies can be first-party or third-party cookies. This varies depending on whether the cookies are sent to your terminal from a computer or domain managed by us (own cookies), or are sent from a computer or domain not managed by us (third party cookies). They can remain active from a few minutes to several years, or only during the session.
Cookies can have many purposes and sometimes several are grouped together. In addition, there is a group of technical cookies that are necessary for the proper functioning of website, being mandatory to obtain consent for the rest of the cookies with different purposes. Depending on their purpose we can distinguish,
If you wish, you can also manage cookies through your browser. Most browsers are set by default to accept cookies, but you can change the settings to block, delete and manage some or all cookies if you prefer. Please be aware of the possible changes that can occur when deleting or blocking cookies.
Chrome:
https://support.google.com/chrome/answer/95647?hl=es
Explorer:
https://support.microsoft.com/es-es/topic/eliminar-y-administrar-cookies-168dab11-0753-043d-7c16-ede5947fc64d
Edge:
https://support.microsoft.com/es-es/microsoft-edge/eliminar-las-cookies-en-microsoft-edge-63947406-40ac-c3b8-57b9-2a946a29ae09
Safari:
- Ipad, Iphone, Ipod Touch: https://support.apple.com/es-es/HT201265
- Mac: Preferencias, Panel de privacidad
Firefox:
https://support.mozilla.org/es/kb/Borrar%20cookies